Doxazosin
- Product NDC
- 0832-0356
- 11-digit product format
- 008320356
- Labeler code
- 0832
- Product ID
- 0832-0356_4367e154-1abf-01ad-e063-6394a90aca53
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin Mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Upsher-Smith laboratories, LLC
- Application
- ANDA209013
- Marketing category
- ANDA
- Marketing start
- 2018-04-17
- Marketing end
- 2027-08-31
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197625, 197626, 197627, 197628 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0832-0356-11 | Doxazosin | 100 in 1 BOTTLE | TABLET | 100 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0832-0356 | DOXAZOSIN (DOXAZOSIN MESYLATE) TABLET [UPSHER-SMITH LABORATORIES, LLC] | 7 | Current NDC, Legacy NDC, 1 package rows | 20230519_b5d1c604-ce3b-4973-845f-9db267a945cd.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0832-0356-11 | 00832035611 | 100 TABLET in 1 BOTTLE (0832-0356-11) | 100 tablet | 2018-04-17 | 2027-01-31 | No | No | Current |